Finasteride Tablet, Film Coated
Product Images NDC 68788-8433

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Finasteride (NDC 68788-8433). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Finasteride Figure 1 (Finasteride Fig.1.jpg)

Finasteride Figure 1 (Finasteride Fig.1.jpg)
Mean change from Baseline + 1 SE of Finasteride at Year 4 for sample sizes of 1438 and 1437 respectively. The values provided are 855 and 965.*
FDA Label Image

Finasteride-fig.2 (Finasteride Fig.2.jpg)

Finasteride-fig.2 (Finasteride Fig.2.jpg)
This data provides information on events and observation time in the Placebo and Finasteride groups. The number of events and cumulative rates are shown for both groups over a period of observation time in months. Additionally, the number at risk per year is provided for each group at specific time points. The data may be used for analyzing the effectiveness of interventions over time.*
FDA Label Image

Finasteride Figure 2 (Finasteride Fig.3.jpg)

Finasteride Figure 2 (Finasteride Fig.3.jpg)
This is a comparison of mean percent change from baseline for two groups: Placebo and Finasteride. The values show a decrease over the years, with Finasteride group having consistently lower values than the Placebo group. The data is presented in a table format indicating the values at Baseline, Year 1, Year 2, Year 3, and Year 4 for both groups.*
FDA Label Image

Finasteride Figure 4 (Finasteride Fig.4.jpg)

Finasteride Figure 4 (Finasteride Fig.4.jpg)
This text provides data on the percentage of individuals experiencing an event at various years from randomization. The chart shows that 25% of the total had an event after 201 years.*
FDA Label Image

Structutre (Finasteride Structure)

Structutre (Finasteride Structure)
This text appears to be a chemical formula containing the structure NHC(CH3)3, with an additional element indicated as Cc=0. It seems to be related to organic chemistry, possibly a compound or a reaction.*
FDA Label Image

Finasteride-fig.3_ (Fig 3finasteride)

Finasteride-fig.3_ (Fig 3finasteride)
The text appears to show a comparison between the placebo group and the finasteride group over an observation period of several months. The text includes percentages of patients in different categories over time, such as the number of events and the number at risk per year in both groups. It provides insights into the outcomes and progression of patients under each treatment.*
FDA Label Image

Finasteride Tablets Usp 5mg (Finasteride 5mg 30tab)

Finasteride Tablets Usp 5mg (Finasteride 5mg 30tab)
This is a description of Finasteride tablets, generic for Proscar, with each film-coated tablet containing 5mg of finasteride USP. The medication is manufactured by Ascend Laboratories, LLC and should be stored at 20°-25°C (68°-77°F), protected from light, and kept in a tightly closed container. It is intended for adult men only and should not be used by women or children. The tablets are round, blue, and imprinted with "FS." The prescription drug is Rx only and caution is advised as federal law prohibits its transfer to anyone other than the prescribed patient. The text provides dosage instructions in English and Spanish, advising to take the tablets once or twice a day. Additionally, details such as package size, expiration date, lot number, batch number, and manufacturer information are available, along with warnings to keep medications out of reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.